Response from Drug Science to the Australian Government consultation on potential reforms to the regulation of nicotine vaping products

Border controls No legislative changes ought to be made to Australia’s current border controls for nicotine products. The black market and mislabelling of nicotine e-liquids exists precisely because Nicotine Vaping…

Continue ReadingResponse from Drug Science to the Australian Government consultation on potential reforms to the regulation of nicotine vaping products

Overdose Prevention Centres, Safe Consumption Sites, and Drug Consumption Rooms: A Rapid Evidence Review

By Dr Gillian W Shorter  Access the Rapid Evidence Review Drug Science is pleased to announce the release of a rapid evidence review collating and synthesizing the existing evidence on…

Continue ReadingOverdose Prevention Centres, Safe Consumption Sites, and Drug Consumption Rooms: A Rapid Evidence Review

Psychedelic therapy in the treatment of addiction: the past, present and future

Authors Rayyan Zafar, Maxim Siegel, Rebecca Harding, Tommaso Barba, Claudio Agnorelli, Shayam Suseelan, Leor Roseman, Matthew Wall, David Nutt and David Erritzoe Published June 12, 2023 Abstract Psychedelic therapy has…

Continue ReadingPsychedelic therapy in the treatment of addiction: the past, present and future

The use of chlordiazepoxide for outpatient gamma-butyrolactone (GBL) detoxification: An observational study

Authors Alfred Balston, Kuljit Hunjan, and Michael J Kelleher Published April 6th, 2023 Background Various detoxification regimens are used for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL), including diazepam, barbiturates, baclofen and…

Continue ReadingThe use of chlordiazepoxide for outpatient gamma-butyrolactone (GBL) detoxification: An observational study